American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy (Q38275214)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy
scientific article

    Statements

    American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy (English)
    Kimberly L Beavers
    Yngve T Falck-Ytter
    American Gastroenterological Association Institute
    215-9; quiz e16-7

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit